Clinical Trial Update: Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating erlotinib combined with Green Tea Extract (Polyphenon E) for preventing cancer recurrence after bladder cancer surgery in former smoker…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)
• Polyphenon E (green tea extract) (green tea polyphenol extract)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED